Patent · US Expired

Compositions and methods to regulate calmodulin gene expression, and uses thereof for influencing cell growth and differentiation

US5981279A · kind A · utility

16Cited by
0References
19Claims
0Family size

Assignee

Inventor

Key dates

Filing dateNov 8, 1996
Grant dateNov 9, 1999
Priority date
Expiry dateNov 8, 2016

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Constructs encoding calmodulin antisense molecules are disclosed. These constructs may be used to advantage to inhibit proliferation of malignant cells. The invention further comprises monoclonal antibody studded liposomes to facilitate cell-type specific delivery of the antisense calmodulin constructs. To enhance cell-type specific expression of calmodulin antisense sequences, cell-type specific promoters are employed to drive expression of the antisense molecules in targeted tissues.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.